Jiangsu Bide Science and Technology Co.,Ltd. (SHA:605298)
China · Delayed Price · Currency is CNY 42.10
+0.23 (0.55%)
At close: Jan 30, 2026
SHA:605298 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 553 | 469.73 | 346.56 | 228.67 | 298.31 | 345.52 |
Other Revenue | 13.31 | 13.31 | 1.63 | 0.87 | 2.4 | 1.98 |
| 566.31 | 483.04 | 348.19 | 229.54 | 300.7 | 347.5 | |
Revenue Growth (YoY) | 37.00% | 38.73% | 51.69% | -23.66% | -13.47% | 11.09% |
Cost of Revenue | 328.13 | 291.58 | 218.87 | 112.7 | 139.26 | 172.44 |
Gross Profit | 238.18 | 191.46 | 129.32 | 116.84 | 161.45 | 175.06 |
Selling, General & Admin | 103.35 | 105.94 | 73.77 | 50.25 | 48.57 | 38.73 |
Research & Development | 28.33 | 25.49 | 26.91 | 22.6 | 22.9 | 19.5 |
Other Operating Expenses | 4.79 | 4.91 | 1.26 | 1.55 | 2.37 | 3.11 |
Operating Expenses | 140.13 | 141.39 | 109.01 | 81.02 | 76.6 | 59.49 |
Operating Income | 98.05 | 50.07 | 20.31 | 35.82 | 84.84 | 115.57 |
Interest Expense | - | - | - | -0.47 | -0.09 | -0.19 |
Interest & Investment Income | 1.73 | 3.57 | 10.31 | 11.45 | 12.16 | 2.26 |
Currency Exchange Gain (Loss) | 0 | 0 | -0 | 0 | -0 | - |
Other Non Operating Income (Expenses) | -0.24 | -0.17 | -0.07 | 0.04 | -0.05 | -0.12 |
EBT Excluding Unusual Items | 99.54 | 53.46 | 30.55 | 46.84 | 96.86 | 117.51 |
Impairment of Goodwill | -1.92 | -1.92 | - | - | - | - |
Gain (Loss) on Sale of Investments | -0.58 | -0.54 | -0.09 | - | - | - |
Gain (Loss) on Sale of Assets | 0.64 | 0.31 | - | 0.21 | - | 0.02 |
Asset Writedown | -1.25 | -0.11 | -0.1 | -0.02 | -0.05 | - |
Other Unusual Items | -2.16 | -2.16 | 7.36 | 6.08 | 0.51 | 4.19 |
Pretax Income | 94.28 | 49.05 | 37.72 | 53.1 | 97.33 | 121.73 |
Income Tax Expense | 16.56 | 10.69 | 7.48 | 6.58 | 12.42 | 17.23 |
Earnings From Continuing Operations | 77.72 | 38.36 | 30.24 | 46.53 | 84.91 | 104.5 |
Minority Interest in Earnings | -0.73 | 0.5 | 0.39 | 0.3 | -0.38 | - |
Net Income | 76.99 | 38.86 | 30.63 | 46.82 | 84.53 | 104.5 |
Net Income to Common | 76.99 | 38.86 | 30.63 | 46.82 | 84.53 | 104.5 |
Net Income Growth | 163.36% | 26.86% | -34.59% | -44.60% | -19.11% | -5.11% |
Shares Outstanding (Basic) | 169 | 185 | 146 | 184 | 177 | 137 |
Shares Outstanding (Diluted) | 169 | 185 | 146 | 184 | 177 | 137 |
Shares Change (YoY) | 11.74% | 26.86% | -20.95% | 4.09% | 29.47% | 0.03% |
EPS (Basic) | 0.45 | 0.21 | 0.21 | 0.25 | 0.48 | 0.76 |
EPS (Diluted) | 0.45 | 0.21 | 0.21 | 0.25 | 0.48 | 0.76 |
EPS Growth | 135.70% | - | -17.26% | -46.78% | -37.52% | -5.15% |
Free Cash Flow | 12.56 | -100.68 | -71.41 | -22.29 | 24.91 | 34.11 |
Free Cash Flow Per Share | 0.07 | -0.54 | -0.49 | -0.12 | 0.14 | 0.25 |
Dividend Per Share | 0.150 | 0.150 | 0.100 | 0.115 | 0.237 | 0.237 |
Dividend Growth | 50.00% | 50.00% | -13.35% | -51.25% | - | 699.66% |
Gross Margin | 42.06% | 39.64% | 37.14% | 50.90% | 53.69% | 50.38% |
Operating Margin | 17.31% | 10.37% | 5.83% | 15.60% | 28.21% | 33.26% |
Profit Margin | 13.59% | 8.04% | 8.80% | 20.40% | 28.11% | 30.07% |
Free Cash Flow Margin | 2.22% | -20.84% | -20.51% | -9.71% | 8.28% | 9.81% |
EBITDA | 126.52 | 70.99 | 31.17 | 43.96 | 92.08 | 122.6 |
EBITDA Margin | 22.34% | 14.70% | 8.95% | 19.15% | 30.62% | 35.28% |
D&A For EBITDA | 28.47 | 20.92 | 10.86 | 8.15 | 7.24 | 7.03 |
EBIT | 98.05 | 50.07 | 20.31 | 35.82 | 84.84 | 115.57 |
EBIT Margin | 17.31% | 10.37% | 5.83% | 15.60% | 28.21% | 33.26% |
Effective Tax Rate | 17.56% | 21.79% | 19.84% | 12.38% | 12.76% | 14.15% |
Revenue as Reported | 566.31 | 483.04 | 348.19 | 229.54 | 300.7 | 347.5 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.